Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6064199 | 0.94 | TSHR (0.36) | TSHRALDH1A1 | |
| SCHEMBL27924074 | 0.85 | TSHR (0.39) | TSHRALDH1A1 | |
| SCHEMBL2143419 | 0.82 | TSHR (0.42) | TSHRALDH1A1 | |
| SCHEMBL2510290 | 0.82 | — | — | |
| SCHEMBL2505437 | 0.80 | — | — | |
| SCHEMBL6063927 | 0.79 | TSHR (0.42) | TSHRALDH1A1 | |
| SCHEMBL235010 | 0.78 | TSHR (0.32) | TSHR | |
| SCHEMBL6558012 | 0.78 | — | — | |
| SCHEMBL6062803 | 0.78 | — | — | |
| SCHEMBL5152967 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180034103-A1 | ELECTROLYTE SOLUTION FOR NON-AQUEOUS ELECTROLYTE BATTERY, AND NON-AQUEOUS ELECTROLYTE BATTERY USING THE SAME | CENTRAL GLASS CO., LTD. (JP) | 2018-02-01 | — | — | US | disclosed |
| EP-3261166-A1 | ELECTROLYTE FOR NONAQUEOUS-ELECTROLYTE CELL, AND NON-AQUEOUS ELECTROLYTE CELL IN WHICH SAME IS USED | Central Glass Co., Ltd. (JP) | 2017-12-27 | — | — | EP | disclosed |
| US-20170222264-A1 | Electrolyte Solution for Non-Aqueous Electrolytic Solution Battery and Non-Aqueous Electrolyte Solution Battery Using Same | CENTRAL GLASS CO., LTD. (JP) | 2017-08-03 | — | — | US | disclosed |
| US-20170222264-A1 | Electrolyte Solution for Non-Aqueous Electrolytic Solution Battery and Non-Aqueous Electrolyte Solution Battery Using Same | CENTRAL GLASS CO., LTD. (JP) | 2017-08-03 | — | — | US | disclosed |
| US-20170204124-A1 | Ionic Complex, Electrolyte for Nonaqueous Electrolyte Battery, Nonaqueous Electrolyte Battery and Ionic Complex Synthesis Method | CENTRAL GLASS COMPANY, LIMITED (JP) | 2017-07-20 | — | — | US | disclosed |
| US-20170204124-A1 | Ionic Complex, Electrolyte for Nonaqueous Electrolyte Battery, Nonaqueous Electrolyte Battery and Ionic Complex Synthesis Method | CENTRAL GLASS COMPANY, LIMITED (JP) | 2017-07-20 | — | — | US | disclosed |
| EP-3166170-A1 | ELECTROLYTE SOLUTION FOR NON-AQUEOUS ELECTROLYTE SOLUTION BATTERY AND NON-AQUEOUS ELECTROLYTE SOLUTION BATTERY USING SAME | Central Glass Co., Ltd. (JP) | 2017-05-10 | — | — | EP | disclosed |
| US-9228107-B2 | (Meth)allylsilane compound, silane coupling agent thereof, and functional material using the same | KYOEISHA CHEMICAL CO., LTD. (JP) | 2016-01-05 | — | — | US | disclosed |
| US-20140200311-A1 | (METH)ALLYLSILANE COMPOUND, SILANE COUPLING AGENT THEREOF, AND FUNCTIONAL MATERIAL USING THE SAME | KYOEISHA CHEMICAL CO., LTD. (JP) | 2014-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140200311-A1 | (METH)ALLYLSILANE COMPOUND, SILANE COUPLING AGENT THEREOF, AND FUNCTIONAL MATERIAL USING THE SAME | FGB, PFAS, MGMT | TSHR 1068/4885ALDH1A1 1601/4885 |
| US-20170204124-A1 | Ionic Complex, Electrolyte for Nonaqueous Electrolyte Battery, Nonaqueous Electrolyte Battery and Ionic Complex Synthesis Method | HCN2, KCNN4, KCNH3 | TSHR 3190/4885ALDH1A1 3265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.